Grants

Grants & Other Sponsored Projects

 

We're working to update the sponsored projects information that appears on this page. Please check back!

Title Principal Investigator Unitsort descending Sponsor Name
A Phase 1/2 Study to Assess the Safety and Efficacy of Lorvotuzumab Mertansine (IMGN901) in Combination with Carboplatin/Etoposide in Patients with ..
Garland,Linda L
Cancer Center Division
ImmunoGen Incorporated
Southwest Oncology Group Operations Office Grant
Krouse,Robert S
Cancer Center Division
University of Michigan
Multi-Modality Imaging of Window Chambers
Gmitro,Arthur F
Cancer Center Division
Arizona Biomedical Research Commission
Exploration of the use of [124I]FIAU Positron Emission Tomography-Computed Tomography Scanning in Diagnosing Osteomyelitis in Patients with Diabetic F
Kuo,Phillip H
Cancer Center Division
Covance, Incorporated
A Randomised Multicenter, Phase III Open-Label Study of the Efficacy and Safety of Trastuzmab-MCC-DM1 vs. Capecitabine + Lapatinib in Patients with...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
An open label, multi-center, phase 3 study with corresponding blinded image to determine the efficacy and safety of a single intravenous injection ..
Kuo,Phillip H
Cancer Center Division
Bayer Healthcare Pharmaceuticals Incorportated
A...Study Evaluating the Efficacy of Doxorubicin With or Without a Human Anti-PDGFRa Monoclonal Antibody (IMC-3G3) in the Treatment of Advanced ...
Cranmer,Lee D
Cancer Center Division
ImClone Systems Corporation
Regional Hemophilia Network-Mountain States
Stopeck,Alison T
Cancer Center Division
Oregon Health and Science University
A-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Fusion Protein ...
Stopeck,Alison T
Cancer Center Division
Biogen Idec, Incorporated
Detecting inherited DNA-repair gene mutations in women with strong family histories of breast cancer
Laukaitis,Christina M
Cancer Center Division
Phi Beta Psi Sorority
A Two-Cohort, Open-Label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination with Tratuzumab and Vinor...
Stopeck,Alison T
Cancer Center Division
Genetech, Incorporated
Phase 1/2 open-label study of the safety & efficacy of PD0332991 in combination w/ bortezomib & dexamethasone in patients w/refractory multiple myeloa
Yeager,Andrew M
Cancer Center Division
INC Research, Incorporated
Southwest Oncology Group Operations Office Grant
Alberts,David S
Cancer Center Division
University of Michigan
Development of folic acid derivatives for skin protection
Gandolfi,A Jay
Cancer Center Division
Niadyne, Incorporated
A Phase II, Open-label, Multicenter Study to Evaluate the Antitumor Efficacy of CO-1.01 for Infusion as Second-Line Therapy for Gemcitabine...
Dragovich,Tomislav
Cancer Center Division
Clovis Oncology, Incorporated
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy (Proclaim)
Jeter,Joanne M
Cancer Center Division
Prometheus Labs
New Combination Therapies for Advanced Prostate Cancer Based on the Radiosensitizing Potential of 5-Azacytidine
Weterings,Eric
Cancer Center Division
United States Army Medical Research and Material Command
Development of an Automated In Situ Test to Perform Molecular Sub-Classification of Prostate Cancer in Standard Prostate Biopsies
Sokoloff,Mitchell H
Cancer Center Division
Ventana Medical Systems, Inc.
Living in Harmony with the Sun
Hiscox,Heather L
Cancer Center Division
University of Arizona Foundation
Physical Activity Form Processing Support
Hamilton,Lynn A
Cancer Center Division
Science Applications International Corporation
A Multicenter Treatment Protocol for Expanded Access Use of Ipilimumab (BMS-734016) in Subjects with Unresectable Stage III or Stahe VI Melanoma
Hersh,Evan M
Cancer Center Division
Bristol-Myers Squibb
Further Investigation of CFZ anti-tumor activity in SCLC in vitro and in vivo models
Garland,Linda L
Cancer Center Division
Onyx Pharmaceuticals
Lymphoma Research Foundation Clinical Career Development Award
Schatz,Jonathan H
Cancer Center Division
Lymphoma Research Foundation
Vida! The Fifth Annual Mujer Latina Breast Cancer Conference
Lopez,Ana Maria
Cancer Center Division
Susan G. Komen Breast Cancer Foundation
Evaluating the Role of Mitochondrial ROS in SCC Cell Proliferation and Migration using Cybrid Model
Jandova,Jana
Cancer Center Division
Dermatology Foundation
The Colon Cancer Family Registry: USC Consortium
Lance,Michael P
Cancer Center Division
University of Southern California
Dalterparin Sodium Injection (Fragmin), Multi-Center,....Malignancies and Symptomatic Venous Thromboembolism
Stopeck,Alison T
Cancer Center Division
EISAI Incorporated
Networks Among Tribal Organizations for Clean Air Policies (NATO CAP)
Leischow,Scott J
Cancer Center Division
National Cancer Institute
Phase I/II Trial of Vorinostat with R-CHOP in Patients with Advanced Stage DLBCL
Persky,Daniel O
Cancer Center Division
The Hope Foundation
Southwest Oncology Group Operations Office Grant
Miller,Thomas P
Cancer Center Division
University of Michigan

Pages

UA@Work is produced by University Communications

888 N. Euclid Ave., Ste. 413 (or) 
P.O. Box 210158, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback

2019 © The Arizona Board of Regents on behalf of the University of Arizona